1. Tumour suppression through modulation of neprilysin signaling: A comprehensive review
   Runali Sankhe et al, 2021, European Journal of Pharmacology CrossRef
2. Pretreatment to Posttreatment Hypoxia Inducible Factor-1α Ratios as a Potentially Predictive Marker for First-Line Treatment in Nonsmall Cell Lung Cancer Patients without Known Driver Mutations
   Mingming Hu et al, 2020, Genetic Testing and Molecular Biomarkers CrossRef
3. New insight into the role of substance P/neurokinin‐1 receptor system in breast cancer progression and its crosstalk with microRNAs
   Safieh Ebrahimi et al, 2020, Clinical Genetics CrossRef
4. Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs
   Sylvie Ricard-Blum et al, 2019, Matrix Biology CrossRef
5. NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
   Alessandra Zingoni et al, 2020, Frontiers in Immunology CrossRef
6. Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
   Charnay Cunningham et al, 2023, Pharmaceuticals CrossRef
7. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status
   J. Anakha et al, 2023, Medical Oncology CrossRef